Risk factors for pneumonitis in patients treated with anti‐programmed death‐1 therapy: A case‐control study

Abstract Immune checkpoint blockade‐related pneumonitis is a rare but potentially life‐threatening adverse effect, but its risk factors are not completely understood. This case‐control study was conducted to identify pneumonitis risk factors in patients treated with anti‐PD1 monoclonal antibodies (m...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Pengfei Cui, Zhefeng Liu, Guoqiang Wang, Junxun Ma, Yuanyu Qian, Fan Zhang, Chun Han, Yaping Long, Ye Li, Xuan Zheng, Danyang Sun, Jing Zhang, Shangli Cai, Shunchang Jiao, Yi Hu
Format:	Artigo
Język:	Inglês
Wydane:	Wiley 2018-08-01
Seria:	Cancer Medicine
Hasła przedmiotowe:	anti‐PD‐1 case‐control study pneumonitis risk factors
Dostęp online:	https://doi.org/10.1002/cam4.1579
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!